Showing 1-10 of 28 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus free features in adults with Type 1 Diabetes | Baker Heart & Diabetes Institute | Neale Cohen | Improving Lives | 01-October-2022 to 28-February-2026 | $746,100.00 |
| Induction of beta-cell regeneration using EZH2 inhibitors | Baker Heart & Diabetes Institute | Sam El-Osta | Cures | 01-October-2023 to 30-September-2025 | $699,447.00 |
| End Diabetes Stigma: Global Summit | Deakin University | Jane Speight | Improving Lives | 01-March-2025 to 28-February-2027 | $500,000.00 |
| Providing blood glucose monitoring, HbA1c testing, and other in-country support to centers enrolled in the Life for a Child Program | Diabetes Australia (fka Diabetes New South Wales) | Graham Ogle | Transportfolio | 01-March-2025 to 28-February-2026 | $800,000.00 |
| Combination immunotherapy with abatacept and nasal insulin | Melbourne Health | John Wentworth | Cures | 01-February-2022 to 30-June-2025 | $575,000.00 |
| Targeted regulatory T cells to treat type 1 diabetes | Monash University | Joshua Ooi | Cures | 01-February-2023 to 31-January-2026 | $510,000.00 |
| α-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes | Monash University | Michael Cowley | Improving Lives | 01-August-2019 to 30-September-2025 | $716,962.40 |
| Engineering an artificial pancreas in the gut for the treatment of diabetes | Monash University | Rong Xu | Improving Lives | 01-September-2025 to 31-August-2028 | $285,000.00 |
| Proof of concept trial of intracutaneous islet transplant | Royal Adelaide Hospital | Patrick Coates | Cures | 01-October-2021 to 31-December-2024 | $285,900.00 |
| Using JAK inhibitors with locally delivered immunosuppression to target islet graft rejection | St. Vincent's Institute of Medical Research | Helen Thomas | Cures | 01-July-2022 to 30-June-2024 | $500,000.00 |